Charles Schwab’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,595
| Closed | -$19K | – | 3567 |
|
|
2022
Q3 | $19K | Hold |
4,595
| – | – | ﹤0.01% | 3483 |
|
|
2022
Q2 | $26K | Buy |
+4,595
| New | +$26K | ﹤0.01% | 3500 |
|
|
2022
Q1 | – | Sell |
-1,259
| Closed | -$19K | – | 3619 |
|
|
2021
Q4 | $19K | Hold |
1,259
| – | – | ﹤0.01% | 3582 |
|
|
2021
Q3 | $38K | Sell |
1,259
-13,099
| -91% | -$395K | ﹤0.01% | 3476 |
|
|
2021
Q2 | $667K | Sell |
14,358
-8,282
| -37% | -$385K | ﹤0.01% | 3075 |
|
|
2021
Q1 | $1.36M | Buy |
22,640
+743
| +3% | +$44.6K | ﹤0.01% | 2756 |
|
|
2020
Q4 | $1.15M | Buy |
21,897
+919
| +4% | +$48.2K | ﹤0.01% | 2728 |
|
|
2020
Q3 | $726K | Buy |
20,978
+2,142
| +11% | +$74.1K | ﹤0.01% | 2764 |
|
|
2020
Q2 | $1.64M | Buy |
18,836
+2,095
| +13% | +$182K | ﹤0.01% | 2481 |
|
|
2020
Q1 | $972K | Buy |
16,741
+1,001
| +6% | +$58.1K | ﹤0.01% | 2495 |
|
|
2019
Q4 | $1.14M | Buy |
15,740
+690
| +5% | +$49.8K | ﹤0.01% | 2555 |
|
|
2019
Q3 | $919K | Buy |
15,050
+8,152
| +118% | +$498K | ﹤0.01% | 2599 |
|
|
2019
Q2 | $656K | Buy |
6,898
+746
| +12% | +$70.9K | ﹤0.01% | 2710 |
|
|
2019
Q1 | $499K | Buy |
6,152
+39
| +0.6% | +$3.16K | ﹤0.01% | 2770 |
|
|
2018
Q4 | $994K | Buy |
6,113
+3,840
| +169% | +$624K | ﹤0.01% | 2540 |
|
|
2018
Q3 | $371K | Buy |
2,273
+225
| +11% | +$36.7K | ﹤0.01% | 2942 |
|
|
2018
Q2 | $309K | Buy |
+2,048
| New | +$309K | ﹤0.01% | 2951 |
|